Xiaoju Zhou
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Molecular Medicine top 10%
- Curcumin's Biomedical Applications
Papers in
-
- RNA Interference and Gene Delivery 4
-
- Nanoparticle-Based Drug Delivery 4
- Co-authors
- Robert J. Lee (6 shared papers)Jing Zhu (1 shared paper)Zhaogang Yang (1 shared paper)Lesheng Teng (1 shared paper)Jing Xie (1 shared paper)Bryant C. Yung (4 shared papers)Wenli Zhang (4 shared papers)Jianhua He (3 shared papers)
- Journals
- Molecular Pharmaceutics (2 papers)Carbohydrate Polymers (2 papers)mAbs (2 papers)Journal of Materials Chemistry B (1 paper)International Journal of Pharmaceutics (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Xiaoju Zhou
27 papers receiving 797 citations
Peers
Comparison fields: 5 of 99
- Biomaterials 228
- Molecular Medicine 62
- Aging 17
- Pharmaceutical Science 55
- Sensory Systems 33
Countries citing papers authored by Xiaoju Zhou
This map shows the geographic impact of Xiaoju Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoju Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoju Zhou more than expected).
Fields of papers citing papers by Xiaoju Zhou
This network shows the impact of papers produced by Xiaoju Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoju Zhou. The network helps show where Xiaoju Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoju Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 124 | |
| 2 | 2012 | 82 | |
| 3 | 2013 | 75 | |
| 4 | 2022 | 65 | |
| 5 | 2016 | 62 | |
| 6 | 2015 | 54 | |
| 7 | 2017 | 41 | |
| 8 | 2015 | 38 | |
| 9 | 2018 | 38 | |
| 10 | 2008 | 31 | |
| 11 | 2019 | 28 | |
| 12 | Novel liposomal gefitinib (L-GEF) formulations. | 2012 | 27 |
| 13 | 2023 | 24 | |
| 14 | 2020 | 23 | |
| 15 | 2014 | 21 | |
| 16 | 2008 | 17 | |
| 17 | 2007 | 14 | |
| 18 | 2022 | 10 | |
| 19 | 2020 | 7 | |
| 20 | 2024 | 6 |
About Xiaoju Zhou
Xiaoju Zhou is a scholar working on Molecular Biology, Biomaterials, Immunology, Pharmaceutical Science and Oncology, having authored 28 papers that have together received 812 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (4 papers), RNA Interference and Gene Delivery (4 papers), Atherosclerosis and Cardiovascular Diseases (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Respiratory viral infections research (2 papers), Drug Solubulity and Delivery Systems (2 papers), Antimicrobial Resistance in Staphylococcus (2 papers) and Cholesterol and Lipid Metabolism (2 papers). The work is most often cited by research in Biomaterials (228 citations), Molecular Medicine (62 citations), Aging (17 citations), Pharmaceutical Science (55 citations) and Sensory Systems (33 citations). Xiaoju Zhou has collaborated with scholars based in China and United States. Frequent co-authors include Robert J. Lee, Jing Zhu, Zhaogang Yang, Lesheng Teng, Jing Xie, Bryant C. Yung, Wenli Zhang, Jianhua He, Li and Zhang. Their work appears in journals such as Molecular Pharmaceutics, Carbohydrate Polymers, mAbs, Journal of Materials Chemistry B and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.